Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

NCT00427895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2141

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)
BIOLOGICAL: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS)
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)
BIOLOGICAL: 23-valent Pneumococcal Polysaccharide Vaccine (23vPS)
BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)

Sponsor

Pfizer